However, low NMNAT1-expressing lung cancer cell lines are more sensitive to the DNA-damaging agent, doxorubicin, compared to high NMNAT1-expressing lung cancer cell lines [108]. This evidence concerns the gene NMNAT1 and lung carcinoma.